Comparing two creams for melasma treatment
Part of Skin clinical trials.
This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 30 and 59 years old.
- You have been diagnosed with melasma (a skin condition causing dark patches) by a doctor.
- Your skin type is IV or V (you tan easily and rarely burn).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not used hormonal birth control in the last 6 months and will not use it during the study.
- You have not used any melasma creams, skin lighteners, or peeling treatments on your face for at least 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding an oral medication (tranexamic acid) to a standard triple cream for melasma works better than the cream alone. It may help if you have medium-to-severe melasma and are generally healthy.
This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.
This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.
This study tests a new gel (SM-030) for adults with moderate to severe melasma. If you join, you would use the gel on your face for a few months and stop other skin-lightening products, while applying the provided sunscreen every day.
This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.
This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.